MAPK1 and Alzheimer disease: Polyphenols and flavonoids are known to have appreciable antioxidant potential and several findings have validated their capability to cross blood-brain barrier and acknowledged their involvement in amelioration of AD via interference with some therapeutic targets like AChE and/or extracellular regulated kinase 2 (ERK2) (Elsawi et al., 2018).